- Home
- WING vs PEN Comparison
WING vs PEN Comparison
Compare WING & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WING
- PEN
- Stock Information
- Founded
- WING 1994
- PEN 2004
- Country
- WING United States
- PEN United States
- Employees
- WING N/A
- PEN N/A
- Industry
- WING Restaurants
- PEN Medical/Dental Instruments
- Sector
- WING Consumer Discretionary
- PEN Health Care
- Exchange
- WING Nasdaq
- PEN Nasdaq
- Market Cap
- WING 9.1B
- PEN 10.0B
- IPO Year
- WING 2015
- PEN 2015
- Fundamental
- Price
- WING $234.02
- PEN $291.61
- Analyst Decision
- WING Buy
- PEN Buy
- Analyst Count
- WING 17
- PEN 16
- Target Price
- WING $365.06
- PEN $287.07
- AVG Volume (30 Days)
- WING 915.3K
- PEN 524.6K
- Earning Date
- WING 02-19-2025
- PEN 02-18-2025
- Dividend Yield
- WING 0.46%
- PEN N/A
- EPS Growth
- WING 57.45
- PEN N/A
- EPS
- WING 3.70
- PEN 0.36
- Revenue
- WING $625,807,000.00
- PEN $1,194,615,000.00
- Revenue This Year
- WING $39.38
- PEN $13.65
- Revenue Next Year
- WING $20.19
- PEN $14.30
- P/E Ratio
- WING $63.25
- PEN $801.77
- Revenue Growth
- WING 36.03
- PEN 12.86
- 52 Week Low
- WING $232.19
- PEN $148.00
- 52 Week High
- WING $433.86
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- WING 25.08
- PEN 65.03
- Support Level
- WING $297.02
- PEN $264.82
- Resistance Level
- WING $314.65
- PEN $310.00
- Average True Range (ATR)
- WING 12.16
- PEN 7.93
- MACD
- WING -7.15
- PEN 2.79
- Stochastic Oscillator
- WING 2.18
- PEN 64.07
About WING Wingstop Inc.
Founded in 1994 in Garland, Texas, Wingstop is a restaurant operator specializing in indulgent bone-in and boneless chicken wings, chicken tenders, fries, and, recently, chicken sandwiches. The firm's footprint has grown quickly since its inception, reaching north of 2,200 global stores at the end of 2023, rendering Wingstop the 31st-largest restaurant brand in the US by system sales, according to Euromonitor data. With a 98% franchised model, Wingstop generates the lion share of its revenue from franchise royalties and advertising fees, with the remainder derived from a small footprint of company-owned stores.
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.